Cefotiam Hexetil is a second-generation cephalosporin antibiotic that is administered intravenously. It is effective against both Gram-positive and Gram-negative bacteria. As a beta-lactam, its bactericidal effect stems from its affinity for penicillin-binding proteins, which inhibits cell wall formation. In 1973, it was granted a patent, and in 1981, it was approved for medicinal usage. Surgical infection, bone and joint infections, bacterial septicaemia, pyelonephritis, postoperative infections, cholangitis, respiratory tract infections, urethritis, peritonitis, skin and soft tissue infections, cholecystitis, cystitis, prostatitis, and infections caused by susceptible organisms are all treated with this drug. It is ineffective against Pseudomonas aeruginosa. Nausea and vomiting, dysentery, hypersensitivity responses, nephrotoxicity, seizures, CNS toxicity, hepatic dysfunction, discomfort at injection site, pseudomembranous colitis, haematologic problems, thrombophloebitis, and superinfection have all been reported as side effects of this medication.

Cefotiam Hexetil is a third-generation, semi-synthetic beta-lactam cephalosporin antibiotic with antibacterial action that comes in a hydrochloride salt form. Cefotiam Hexetil binds to penicillin-binding proteins (PBPs), which are transpeptidases responsible for peptidoglycan crosslinking. Cell wall integrity is compromised and cell wall production is inhibited when peptidoglycan cross linking is prevented. Cefotiam Hexetil prevents bacterial cell wall formation by blocking the final cross-linking stage of peptidoglycan biosynthesis. It has equivalent or lower action against Gram-positive staphylococci and streptococci, but is resistant to several Gram-negative bacteria's beta-lactamases. Many Enterobacteriaceae, such as Enterobacter, E. coli, Klebsiella, Salmonella, and indole-positive Proteus species, are more resistant to it.

An online search for the wholesale price for sale of Cefotiam Hexetil for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Cefotiam Hexetil distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Cefotiam Hexetil suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Cefotiam Hexetil. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Cefotiam Hexetil is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers and Cefotiam Hexetil suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Cefotiam Hexetil Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.